-Caveat Lector-

WJPBR Email News List [EMAIL PROTECTED]
Peace at any cost is a Prelude to War!

Anthrax Vaccine Maker Didn't Report Army Sergeant's Death, According to FDA

Mar 6, 2001
Dave Eberhart
Stars and Stripes Veterans Affairs Editor



The Pentagon's lone anthrax vaccine manufacturer failed to report a
vaccine-related death that occurred in June 2000, according to an Oct. 26,
2000, Food and Drug Administration report of an inspection at the BioPort
Corp. plant in Lansing, Mich.

BioPort also failed to investigate or react to reports by the Pentagon's
Vaccine Adverse Event Reporting System (VAERS) of servicemembers becoming ill
after receiving one or more shots in the DoD's Anthrax Vaccine Inoculation
Program (AVIP), according to the report, a copy of which was obtained by The
Stars and Stripes.

The FDA said: "The military reported a death of an individual who had
received Anthrax vaccine lot #FA V031. The individual was inoculated on
3/14/00 and died on 6/14/00. The cause of death is reported as Aplastic
Anemia and Invasive Aspergillosis. The firm received information in a VAERS
form but there is no documentation as to when that report was received by the
firm [BioPort]."

Blood Disorder






Redmond Handy



Redmond Handy, president of the National Organization of Americans Battling
Unnecessary Servicemember Endangerment (NO ABUSE), told The Stars and Stripes
Feb. 5 that the servicemember involved was Sandra Larson, an Army sergeant
whose sister, Nancy Rugo, testified before the House Government Reform
Committee last year that Larson had died of an autoimmune blood disorder. She
said Larson had blamed the anthrax vaccine for her illness.

Rugo told lawmakers that Sandra Larson joined the Army in 1995 and was
transferred to South Korea in 1998, where she began the 18-month vaccine
program and received four of the six required shots from lot 17. In October
1999 she was transferred to Fort Riley, Kan., where she received the final
two shots, from lot 44 in September of that year and from lot 31 in March
2000.


On April 7, 2000, just four weeks after being injected from her sixth shot,
[Sandra Larson] was admitted into the hospital with a serious rare blood
disease.
- Nancy Rugo




"On April 7, 2000, just four weeks after being injected from her sixth shot,
[Sandra Larson] was admitted into the hospital with a serious rare blood
disease, aplastic anemia, which could be considered an autoimmune disease,"
Rugo testified. "On June 14, 2000, twelve weeks after receiving her sixth
shot, she had deceased."

"This was not a gradual case of aplastic anemia," Rugo said. "She went from a
healthy woman just four weeks prior to having no bone marrow, platelets and
an extremely low count of red and white blood cells. It was as if there was
something in her that was killing her immune system, shutting her down."

"The firm [BioPort] has not reported the death to FDA in a 15-day report. The
firm has not conducted an investigation [of the death] as a result of this
VAERS report," said the FDA report, which was prepared by inspectors Marsha
W. Major, William D. Tingley and Paula A. Trost.

'No Documentation'

And, the report said, "The firm does not trend data received relating to
adverse events. Further, there is no documentation to show that the firm
investigates adverse events [drug reactions] when received."

Uninvestigated adverse events included "nausea, diarrhea, vomiting, double
vision, dizziness, memory loss, shortness of breath, and blackouts," the
inspectors reported.

The FDA report identified three anthrax vaccine lots that failed initial
sterility testing. One lot "was retested and failed the retest," the report
said. The FDA characterized BioPort's investigations into the initial
sterility test failures as incomplete and "not addressing corrective actions
relating to [BioPort] personnel."

The report cited a "lack of reconciliation of vials that are returned to the
firm from customers" on the part of BioPort. In one instance, according to
the report, BioPort was discovered to have changed its records on the number
of anthrax vaccine vials returned by the military for destruction.


Larson's death is being investigated by several organizations, including the
FDA and the anthrax vaccine expert committee, a group of civilian physicians
that reviews VAERS reports.
- Bioport




BioPort spokeswoman Kim Brennan Root told The Stars and Stripes Feb. 6 that
Larson's death "is being investigated by several organizations, including the
FDA and the anthrax vaccine expert committee, a group of civilian physicians
that reviews VAERS reports." The committee members are appointed by the FDA,
Root said.

Probe 'Not Complete'

"What we'll do is an investigation based on that report" by the committee,
Root said. "I'm not sure what that investigating will be. In my opinion, the
investigation is not complete."

Referring to the VAERS report of Larson's death, Root said: "That is the
first VAERS report filed by the military implicating the vaccine that we know
of."

Root's response concerning the reported lack of a timely reaction to the
Larson VAERS: "We received that report the day the FDA inspectors arrived
[Oct. 6, 2000]." She said that BioPort has since put new software into play
"to turn that data in a way that will be compliant with the way FDA wants us
to do it."

Robert C. Myers, BioPort's chief scientific officer, earlier had defended the
vaccine and his company's manufacturing process, saying: "Now licensed for
thirty years, with two million doses given in the last two and a half years
alone, the vaccine is proven safe. In total, there have been 13 safety
studies of many different types involving 366,000 patients and there is no
pattern emerging that would call the vaccine's safety into question."

"Anthrax vaccine is also purer than the diphtheria and tetanus vaccines we
give our children and is safe or safer than these and other vaccines we give
to our children and take ourselves as adults," he said.

And a Pentagon spokesmen said: "Thirty years of experience with anthrax
vaccine in the United States suggests that it has a side-effect profile
similar to other commonly used vaccines. The Army is conducting a long-term,
prospective study using a cohort of 600 soldiers at Tripler Army Medical
Center in Honolulu. The intent is to identify side effects that may be
associated with the anthrax vaccine. Thirteen human safety studies affirm the
safety of anthrax vaccine."

Production Quotas

Dr. Meryl Nass, a longtime AVIP critic, told The Stars and Stripes Feb. 6: "I
feel just as I did when I commented on the first inspection report I ever saw
of BioPort in early '98: It looks as if the manufacturer was solely trying to
meet production quotas, with no thought ever being paid to the fact that this
product would be injected into human beings."

"The amazing thing is that after three years of similar inspection reports,
millions of taxpayer dollars and a multitude of experts, they remain so far
off the mark," said Nass. "Where is the quality assurance? I sent a Canadian
bio-defense expert a copy of a BioPort inspection report, and he said he
couldn't sleep that night."

FDA Warned BioPort of Mad Cow

Bovine-derived materials have traditionally been used in the manufacture of
vaccines. Bovine spongiform encephalopathy (BSE), the deadly "mad cow
disease," was first reported in the United Kingdom in the 1980s.
Animal-derived products used in vaccine production can include amino acids,
glycerol, detergents, gelatin, enzymes and blood.

To minimize the possibility of contamination, the FDA, in 1993 and again in
1996 recommended that manufacturers, including BioPort, not use materials
derived from cattle that were born, raised or slaughtered in countries where
BSE is known to exist. The FDA also alerted manufacturers to a U.S.
Department of Agriculture list of countries producing potentially BSE-tainted
beef.

But despite such warnings, the FDA's Center for Biologics Evaluation and
Research last fall reported that BioPort was still using bovine-derived
materials of unknown geographical origin.



*COPYRIGHT NOTICE** In accordance with Title 17 U. S. C. Section 107,
any copyrighted work in this message is distributed under fair use
without profit or payment to those who have expressed a prior interest
in receiving the included information for nonprofit research and educational
purposes only.[Ref. http://www.law.cornell.edu/uscode/17/107.shtml ]

Want to be on our lists?  Write at [EMAIL PROTECTED] for a menu of our lists!

<A HREF="http://www.ctrl.org/">www.ctrl.org</A>
DECLARATION & DISCLAIMER
==========
CTRL is a discussion & informational exchange list. Proselytizing propagandic
screeds are unwelcomed. Substance—not soap-boxing—please!  These are
sordid matters and 'conspiracy theory'—with its many half-truths, mis-
directions and outright frauds—is used politically by different groups with
major and minor effects spread throughout the spectrum of time and thought.
That being said, CTRLgives no endorsement to the validity of posts, and
always suggests to readers; be wary of what you read. CTRL gives no
credence to Holocaust denial and nazi's need not apply.

Let us please be civil and as always, Caveat Lector.
========================================================================
Archives Available at:
http://peach.ease.lsoft.com/archives/ctrl.html
 <A HREF="http://peach.ease.lsoft.com/archives/ctrl.html">Archives of
[EMAIL PROTECTED]</A>

http:[EMAIL PROTECTED]/
 <A HREF="http:[EMAIL PROTECTED]/">ctrl</A>
========================================================================
To subscribe to Conspiracy Theory Research List[CTRL] send email:
SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]

To UNsubscribe to Conspiracy Theory Research List[CTRL] send email:
SIGNOFF CTRL [to:] [EMAIL PROTECTED]

Om

Reply via email to